-
Wednesday's Hot Stocks: Finding A Rose Among Many Thorns
Thursday, January 14, 2010 - 9:42am | 2317With the major indices ticking slightly higher Wednesday, there were many stocks which broke out to the upside on BIG volume. If this is your first time reading one of my breakout reports you'll want to read the section below, however if you are familiar with my daily breakout report you should...
-
Benzinga’s Volume Movers (XRTX, ASYS, BIDU, FMBI, ILMN)
Wednesday, January 13, 2010 - 2:46pm | 222Xyratex Ltd (NASDAQ: XRTX) shares climbed 6.82% to $16.29. The volume of XRTX shares traded was 895% higher than normal. The data storage company announced Q4 profits and an optimistic guidance for 1Q10. Amtech Systems Inc (NASDAQ: ASYS) shares jumped 13.77% to $11.98. The volume of ASYS shares...
-
Barclays Bearish on AFFX
Wednesday, January 13, 2010 - 1:55pm | 40Barclays downgraded Affymetrix (NASDAQ: AFFX) from “equal weight” to “underweight.” AFFX last traded at 6.44 and has moved up 75.96% over the past 52 weeks. The target price for AFFX has been reduced from $6 to $3.
-
Tuesday's Breakout Stocks: Pumping up Your Portfolio with NBTY
Wednesday, January 13, 2010 - 9:12am | 1617With the market taking a hit today on the back of a weak Alcoa (AA) earnings report, there were several stocks which fought the trend and finished higher on heavier volume. If this is your first time reading one of my breakout reports you'll want to read the section below, however if you are...
-
Top 5 Mid-Cap Stocks With The Highest 50-Day Moving Average (ILMN, NYT, LEN, X, GCI)
Wednesday, January 13, 2010 - 7:20am | 226Below are the top 5 mid-cap stocks on the NASDAQ and the NYSE in terms of last price down verses 50 day moving average. Shares of Illumina Inc (NASDAQ: ILMN) are down 32.32% as compared to the 50-day moving average. ILMN’s market capitalization is $4.9 billion. Caris & Company upgraded ILMN...
-
Benzinga’s Volume Movers (STST, QLGC, AMAG, SORL, XRTX)
Tuesday, January 12, 2010 - 3:50pm | 206ARGON ST Inc (NASDAQ: STST) shares rose 3.30% to $24.76. The volume of STST shares traded was 401% higher than normal. STST is considering strategic options, including a potential sale of the company, a merger or an acquisition. QLogic Corporation (NASDAQ: QLGC) shares jumped 8.47% to $20.50. The...
-
AMAG Pharma Upgraded (AMAG)
Tuesday, January 12, 2010 - 3:12pm | 92Citigroup (NYSE: C) upgraded shares of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today. Yesterday the biotech firm said it expects up to $13 million in sales for its anemia drug Feraheme in the fourth quarter, which topped analysts' estimates. The stock is up another 5.4% today to $51.02 after...
-
Luminex Beats Street Expectations (LMNX)
Tuesday, January 12, 2010 - 9:01am | 107Luminex Corporation (NASDAQ: LMNX) released a 8-K filing in which the company tightened and lowered its 2009 full year guidance from $118mn-$126mn to $119mn-$121mn. This implies a 4Q revenue guidance of $ 36.5mn to $38.5mn above consensus estimates of $34.7 million. Analysts at Thomas Weisel...
-
Benzinga’s Volume Movers (DRWI, OSIS, PRXL, TEVA, ASEI)
Friday, January 8, 2010 - 2:25pm | 221Dragonwave Inc (NASDAQ: DRWI) shares rose 6.83% to $12.98. The volume of DRWI shares traded was 1184% higher than normal. DRWI posted impressive FQ3 results, with revenues rising by 421% y/y and net income doubling from the previous quarter. OSI Systems Inc (NASDAQ: OSIS) shares rose 11.11% to $32...
-
Zacks Analyst Blog Highlights: Johnson & Johnson, ViroPharma, Theravance, Cubist Pharmaceutical and Pfizer - Press Releases
Monday, January 4, 2010 - 8:46am | 1010For Immediate Release Chicago, IL – January 4, 2010 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include:...
-
Pipeline Setback for JNJ - Analyst Blog
Thursday, December 31, 2009 - 11:43am | 648Johnson and Johnson (JNJ) has received yet another setback related to its pipeline candidate ceftobiprole, a broad-spectrum antibiotic − aiming the methicillin-resistant Staphylococcus aureus (MRSA) − for the treatment of complicated skin infections and nosocomial pneumonia. Johnson and Johnson had...
-
Benzinga’s Top Pre- Market Losers (CBAK, JASO, JNJ, QGEN, ACAS, MPEL, EGLE)
Wednesday, December 30, 2009 - 9:36am | 360China BAK Battery Inc.’s (NASDAQ: CBAK) has decreased $0.95 or 26.10% to $2.69 in the pre-market session after China BAK’s Chief Financial Officer, Tony Shen, today said in an interview that China BAK hasn’t won any orders from Google Inc. (NASDAQ: GOOG). The 52-week trading range for CBAK is $0....
-
New 52-Week High Stocks (FSII, CGEN, MRM, CRIS)
Monday, December 28, 2009 - 10:49am | 168FSI International, Inc. (NASDAQ: FSII) hits a new 52-week high today at $3.04 in today’s morning trade. Currently, FSI International is trading at $3.03, up 8.21%. So far in the current year, FSII gained over 880%. Compugen Ltd. (USA) (NASDAQ: CGEN) has soared 38.97% to $5.65 on 1.67 million...
-
Compugen Ltd. (USA) (NASDAQ: CGEN) Climbs after Drug Discovery
Monday, December 28, 2009 - 10:42am | 103Compugen Ltd. (USA) (NASDAQ: CGEN) today announced the discovery and experimental validation of a new drug, CGEN-671, used for the treatment of multiple epithelial tumors. The potential application of CGEN-671 as a drug target was initially predicted by Compugen, through the use of its Monoclonal...
-
Benzinga’s News Roundup (CALM, CGEN, VICL, TOBC, TEG, ACTU)
Monday, December 28, 2009 - 10:05am | 420Cal-Maine Foods, Inc. (NASDAQ: CALM) today reported that a second-quarter earnings of $16.1 million or $0.67 a share against $27.2 million, or $1.14 a share from the same quarter last year. Sales declined to $229.2 million as compared to $238.3 million in the year ago period. Cal-Maine Foods also...